The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator

Oncogene

Volumn 18, Issue 21, 1999, Pages 3303-3308

  Labelle, Yves ^a,b   Bussières, Johanne ^a,b   Courjal, Frank ^a,b   Goldring, Mary B ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Chondrosarcomas; EWS; EWS TEC; Fusion proteins; Nuclear receptors; Transcriptional activation

Indexed keywords

CELL NUCLEUS RECEPTOR; HYBRID PROTEIN; RNA BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARTILAGE CELL; CELL PROLIFERATION; CELL STRAIN COS1; CHONDROSARCOMA; CHROMOSOME TRANSLOCATION 9; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; TRANSCRIPTION INITIATION;

ANIMALS; ARTIFICIAL GENE FUSION; CHONDROSARCOMA; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; COS CELLS; DNA-BINDING PROTEINS; HUMANS; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RESPONSE ELEMENTS; SARCOMA, EWING'S; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0033609413     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202675     Document Type: Article

References (36)

1. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J. (1994). Mol. Cell. Biol., 14, 3230-3241.
2. Bertolotti A, Melot T, Acker J, Vigneron M, Delattre O and Tora L. (1998). Mol. Cell. Biol., 18, 1489-1497.
3. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL and Ladanyi M. (1997). Am. J. Pathol., 150, 1049-1058.
4. Buono P, Deconciliis L, Izzo P and Salvatore F. (1997). Biochem. J., 323, 245-250.
5. Calvio C, Neubauer G, Mann M and Lamond AI. (1995). RNA, 1, 724-733.
6. Castillo SO, Xiao Q, Lyu MS, Kozak CA and Nikodem VM. (1997). Genomics, 41, 250-257.
7. Clark J, Benjamin H, Gill S, Sidhar S, Goodwin G, Crew J, Gusterson BA, Shipley J and Cooper CS. (1996). Oncogene, 12, 229-235.
8. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A and Thomas G. (1992). Nature, 359, 162-165.
9. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN and Reddy ESP. (1996). Oncogene, 12, 159-167.
10. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, Arbiser JL and Apperley JF. (1994). J. Clin. Invest., 94, 2307-2316.
11. Graham FL and van der Eb AJ. (1973). Virology, 52, 456-467.
12. Hedvat CV and Irving SG. (1995). Mol. Endocrinol., 9, 1692-1700.
13. Jeon IN, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT and Shapiro DN. (1995). Oncogene, 10, 1229-1234.
14. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F and Fujinaga K. (1996). Genes Chromosom. Cancer, 15, 115-121.
15. Labelle Y, Zucman J, Stenman G, Kindblom LG, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M, Aurias A, Delattre O and Thomas G. (1995). Hum. Mol. Genet., 4, 2219-2226.
16. Ladanyi M and Gerald W. (1994). Cancer Res., 54, 2837-2840.
17. Law SW, Conneely OM, DeMayo FJ and O'Malley BW. (1992). Mol. Endocrinol., 6, 2129-2135.
18. Lessnick SL, Braun BS, Denny CT and May WA. (1995). Oncogene, 10, 423-431.
19. Lin HH, Tu ZJ and Ann DK. (1996). J. Biol. Chem., 271, 27637-27644.
20. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R and Denny CT. (1993). Mol. Cell. Biol., 13, 7393-7398.
21. Milbrandt J. (1988). Neuron, 1, 183-188.
22. Ohkura N, Hijikuro M, Yamamoto A and Miki K. (1994). Biochem. Biophys. Res. Commun., 205, 1959-1965.
23. Ohkura N, Ito M, Tsukada T, Sasaki K, Yamaguchi K and Miki K. (1996). Biochim. Biophys. Acta, 1308, 205-214.
24. Ohno T, Rao VN and Reddy ESP. (1993). Cancer Res., 53, 5859-5863.
25. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN and Reddy ESP. (1994). 9, 3087-3097.
26. Panagopoulos I, Höglund M, Mertens F, Mandahl N, Mitelman F and Aman P. (1996). Oncogene, 12, 489-494.
27. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H and Delattre O. (1997). Oncogene, 14, 1159-1164.
28. Scearce LM, Laz TM, Hazel TG, Lau LF and Taub R. (1993). J. Biol. Chem., 268, 8855-8861.
29. Sorensen PHB, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ and Denny CT. (1994). Nature Genet., 6, 146-151.
30. Urano F, Umezawa A, Hong W, Kikuchi H and Hata J. (1996). Biochem. Biophys. Res. Commun., 219, 608-612.
31. Wilson TE, Fahrner TJ, Johnston M and Milbrandt J. (1991). Science, 252, 1296-1300.
32. Wilson TE, Fahrner TJ and Milbrandt J. (1993a). Mol. Cell. Biol., 13, 5794-5804.
33. Wilson TE, Mouw AR, Weaver CA, Milbrandt J and Parker KL. (1993b). Mol. Cell. Biol., 13, 861-868.
34. Zipfel PF, Irving SG, Kelly K and Siebenlist U. (1989). Mol. Cell. Biol., 9, 1041-1048.
35. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G and Delattre O. (1993a). EMBO J., 12, 4481-4487.
36. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CDM, Aurias A and Thomas G. (1993b). Nature Genet., 4, 341-344.